vs
Side-by-side financial comparison of GoPro, Inc. (GPRO) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($339.0M vs $201.7M, roughly 1.7× GoPro, Inc.). On growth, GoPro, Inc. posted the faster year-over-year revenue change (0.4% vs -2.7%). HAEMONETICS CORP produced more free cash flow last quarter ($87.2M vs $15.0M). Over the past eight quarters, GoPro, Inc.'s revenue compounded faster (13.9% CAGR vs 0.4%).
GoPro, Inc. is an American technology company founded in 2002 by Nick Woodman. It manufactures action cameras and develops its own mobile apps and video-editing software. Founded as Woodman Labs, Inc, the company is based in San Mateo, California.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
GPRO vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $201.7M | $339.0M |
| Net Profit | — | $44.7M |
| Gross Margin | 31.8% | 59.7% |
| Operating Margin | -4.1% | 19.9% |
| Net Margin | — | 13.2% |
| Revenue YoY | 0.4% | -2.7% |
| Net Profit YoY | — | 19.3% |
| EPS (diluted) | $-0.06 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $201.7M | $339.0M | ||
| Q3 25 | $162.9M | $327.3M | ||
| Q2 25 | $152.6M | $321.4M | ||
| Q1 25 | $134.3M | $330.6M | ||
| Q4 24 | $200.9M | $348.5M | ||
| Q3 24 | $258.9M | $345.5M | ||
| Q2 24 | $186.2M | $336.2M | ||
| Q1 24 | $155.5M | — |
| Q4 25 | — | $44.7M | ||
| Q3 25 | $-21.3M | $38.7M | ||
| Q2 25 | $-16.4M | $34.0M | ||
| Q1 25 | $-46.7M | $58.0M | ||
| Q4 24 | — | $37.5M | ||
| Q3 24 | $-8.2M | $33.8M | ||
| Q2 24 | $-47.8M | $38.4M | ||
| Q1 24 | $-339.1M | — |
| Q4 25 | 31.8% | 59.7% | ||
| Q3 25 | 35.1% | 59.5% | ||
| Q2 25 | 35.8% | 59.8% | ||
| Q1 25 | 32.1% | 58.4% | ||
| Q4 24 | 34.7% | 55.5% | ||
| Q3 24 | 35.5% | 54.2% | ||
| Q2 24 | 30.5% | 52.0% | ||
| Q1 24 | 34.1% | — |
| Q4 25 | -4.1% | 19.9% | ||
| Q3 25 | -9.8% | 17.9% | ||
| Q2 25 | -9.2% | 16.8% | ||
| Q1 25 | -33.7% | 21.6% | ||
| Q4 24 | -19.5% | 16.9% | ||
| Q3 24 | -3.1% | 15.0% | ||
| Q2 24 | -25.0% | 11.8% | ||
| Q1 24 | -26.6% | — |
| Q4 25 | — | 13.2% | ||
| Q3 25 | -13.0% | 11.8% | ||
| Q2 25 | -10.8% | 10.6% | ||
| Q1 25 | -34.8% | 17.5% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | -3.2% | 9.8% | ||
| Q2 24 | -25.7% | 11.4% | ||
| Q1 24 | -218.1% | — |
| Q4 25 | $-0.06 | $0.95 | ||
| Q3 25 | $-0.13 | $0.81 | ||
| Q2 25 | $-0.10 | $0.70 | ||
| Q1 25 | $-0.30 | $1.17 | ||
| Q4 24 | $-0.22 | $0.74 | ||
| Q3 24 | $-0.05 | $0.66 | ||
| Q2 24 | $-0.31 | $0.74 | ||
| Q1 24 | $-2.24 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.7M | $363.4M |
| Total DebtLower is stronger | $44.3M | $1.2B |
| Stockholders' EquityBook value | $76.5M | $911.5M |
| Total Assets | $428.0M | $2.5B |
| Debt / EquityLower = less leverage | 0.58× | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $49.7M | $363.4M | ||
| Q3 25 | $152.8M | $296.4M | ||
| Q2 25 | $58.6M | $292.9M | ||
| Q1 25 | $69.6M | $306.8M | ||
| Q4 24 | $102.8M | $320.8M | ||
| Q3 24 | $130.2M | $299.3M | ||
| Q2 24 | $133.0M | $344.4M | ||
| Q1 24 | $133.7M | — |
| Q4 25 | $44.3M | $1.2B | ||
| Q3 25 | $43.9M | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $93.1M | — | ||
| Q2 24 | $92.9M | — | ||
| Q1 24 | $92.7M | — |
| Q4 25 | $76.5M | $911.5M | ||
| Q3 25 | $80.5M | $849.2M | ||
| Q2 25 | $97.9M | $882.3M | ||
| Q1 25 | $110.0M | $820.8M | ||
| Q4 24 | $151.7M | $906.9M | ||
| Q3 24 | $183.9M | $878.9M | ||
| Q2 24 | $184.7M | $905.4M | ||
| Q1 24 | $224.9M | — |
| Q4 25 | $428.0M | $2.5B | ||
| Q3 25 | $538.6M | $2.4B | ||
| Q2 25 | $439.0M | $2.5B | ||
| Q1 25 | $462.5M | $2.5B | ||
| Q4 24 | $543.7M | $2.5B | ||
| Q3 24 | $661.6M | $2.5B | ||
| Q2 24 | $556.8M | $2.5B | ||
| Q1 24 | $575.8M | — |
| Q4 25 | 0.58× | 1.34× | ||
| Q3 25 | 0.55× | 1.44× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.51× | — | ||
| Q2 24 | 0.50× | — | ||
| Q1 24 | 0.41× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.6M | $93.6M |
| Free Cash FlowOCF − Capex | $15.0M | $87.2M |
| FCF MarginFCF / Revenue | 7.4% | 25.7% |
| Capex IntensityCapex / Revenue | 0.3% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | $-24.0M | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.6M | $93.6M | ||
| Q3 25 | $12.2M | $111.3M | ||
| Q2 25 | $8.8M | $17.4M | ||
| Q1 25 | $-57.2M | $116.6M | ||
| Q4 24 | $-25.1M | $43.8M | ||
| Q3 24 | $-2.2M | $48.8M | ||
| Q2 24 | $605.0K | $-27.4M | ||
| Q1 24 | $-98.4M | — |
| Q4 25 | $15.0M | $87.2M | ||
| Q3 25 | $11.2M | $106.3M | ||
| Q2 25 | $8.3M | $13.6M | ||
| Q1 25 | $-58.5M | $100.9M | ||
| Q4 24 | $-25.5M | $35.2M | ||
| Q3 24 | $-4.2M | $39.4M | ||
| Q2 24 | $-111.0K | $-33.1M | ||
| Q1 24 | $-99.4M | — |
| Q4 25 | 7.4% | 25.7% | ||
| Q3 25 | 6.9% | 32.5% | ||
| Q2 25 | 5.4% | 4.2% | ||
| Q1 25 | -43.5% | 30.5% | ||
| Q4 24 | -12.7% | 10.1% | ||
| Q3 24 | -1.6% | 11.4% | ||
| Q2 24 | -0.1% | -9.8% | ||
| Q1 24 | -63.9% | — |
| Q4 25 | 0.3% | 1.9% | ||
| Q3 25 | 0.6% | 1.5% | ||
| Q2 25 | 0.3% | 1.2% | ||
| Q1 25 | 1.0% | 4.7% | ||
| Q4 24 | 0.2% | 2.5% | ||
| Q3 24 | 0.8% | 2.7% | ||
| Q2 24 | 0.4% | 1.7% | ||
| Q1 24 | 0.6% | — |
| Q4 25 | — | 2.09× | ||
| Q3 25 | — | 2.88× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | — | -0.71× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GPRO
| Subscription And Services | $106.3M | 53% |
| Other | $95.4M | 47% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
